Celgene Manager, Business Planning & Analysis in Summit, New Jersey
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Responsibilities will include, but are not limited to, the following:
Leads the forecast, budget and analysis for late development CR&D study budgets, including development and management of individual clinical study budgets, analysis of the actual spending and calculation of clinical study accruals in accordance with GAAP.
Collaborates with a cross functional team (Project Leadership, Sourcing, Clinical Operations, etc.) regarding the study/program status and development/evolution of study budgets to ensure transparency of scope and changes.
Develops dynamic financial models supporting the study forecasts used to assess various business cases.
As part of monthly general ledger closing, prepares journal entries for required accruals, reclassifications or other adjustments resulting from review of operations. Works closely with the Finance Shared Service Center to ensure complete and accurate accounting and timely closings.
Proactively monitors the study assumptions to ensure that forecasts are maintained and updated as accurately and rigorously as possible.
Assists with periodic management reporting to project teams and governance committees regarding study performance relative to budget.
Assists with preparation of financial presentations and highlight reports for Senior Management.
Ensures integrity of financial data by regularly reviewing and reconciling data shared between key financial applications used within the function.
Ad-hoc projects as required
5-8 years of Finance/ Accounting experience with 3 years in a financial analysis role. Experience in R&D preferred.
Excellent skills and proficiency with Microsoft Office products e.g. Excel, Access and PowerPoint. Knowledge of business intelligence software (e.g.OBIEE, Hyperion, Oracle) and experience with integrated accounting software a plus.
Ability to work as a team player in a very fast-paced environment.
Ability to tailor work approach from detail oriented to strategic overview depending on audience.
Ability to identify existing or potential deficiencies in operating processes or procedures and proactively recommend solutions.
Strong communication skills and the ability to interact with all levels of management and the ability to influence processes across multiple functions and geographies
Travel as required (15%)
High sense of urgency and ability to identify creative solutions to, time sensitive problems by balancing achievement of process objectives with practical considerations
Flexible personality who easily adapts to the fast-moving business environment
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.